{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T19:14:10Z","timestamp":1794338050938,"version":"4.9.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":60,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","intpsychogeriatrics.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Psychogeriatrics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1017\/s1041610223000844","type":"journal-article","created":{"date-parts":[[2023,10,20]],"date-time":"2023-10-20T04:53:04Z","timestamp":1697777584000},"page":"1110-1127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Impact of psychotropic medications on cognition among older adults: a systematic review"],"prefix":"10.1016","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2295-852X","authenticated-orcid":false,"given":"Susmita","family":"Chandramouleeshwaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waqas U.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Inglis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8324-2560","authenticated-orcid":false,"given":"Tarek K.","family":"Rajji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1017\/S1041610223000844_bb0010","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jamda.2020.06.028","article-title":"Antidepressant use and progression of mild to moderate Alzheimer\u2019s disease: results from the European ICTUS Cohort","volume":"22","author":"Abdeljalil","year":"2021","journal-title":"Journal of the American Medical Directors Association"},{"key":"10.1017\/S1041610223000844_bb0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.medcli.2020.02.006","article-title":"Association between benzodiazepine use and development of dementia","volume":"156","author":"Aldaz","year":"2021","journal-title":"Medicina Clinica"},{"key":"10.1017\/S1041610223000844_bb0020","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/gps.891","article-title":"Consumption of psychotropic medication in the elderly: a re-evaluation of its effect on cognitive performance","volume":"18","author":"Allard","year":"2003","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0025","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1192\/bjp.bp.115.180463","article-title":"Prevalence of mental disorders in elderly people: the European MentDis_ICF65+ study","volume":"210","author":"Andreas","year":"2017","journal-title":"British Journal of Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0030","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s40266-019-00743-z","article-title":"Adverse effects of anticholinergic drugs on cognition and mobility: cutoff for impairment in a cross-sectional study in young-old and old-old adults","volume":"37","author":"Attoh-Mensah","year":"2020","journal-title":"Drugs and Aging"},{"key":"10.1017\/S1041610223000844_bb0035","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m13205","article-title":"To be continued? Long-term treatment effects of antidepressant drug classes and individual antidepressants on the risk of developing dementia: a german case-control study","volume":"81","author":"Bartels","year":"2020","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0040","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1176\/appi.ajp.2017.17040404","article-title":"Impact of SSRI therapy on risk of conversion from mild cognitive impairment to Alzheimer\u2019s dementia in individuals with previous depression","volume":"175","author":"Bartels","year":"2018","journal-title":"The American Journal of Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0045","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1177\/089826439600800107","article-title":"The use of psychoactive medications and cognitive function in older adults","volume":"8","author":"Berg","year":"1996","journal-title":"Journal of Aging and Health"},{"key":"10.1017\/S1041610223000844_bb0050","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/gps.1811","article-title":"The effect of chronic benzodiazepine use on cognitive functioning in older persons: good, bad or indifferent?","volume":"22","author":"Bierman","year":"2007","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s12603-016-0787-x","article-title":"Anticholinergic burden and functional status in older people with cognitive impairment: results from the regal project","volume":"21","author":"Boccardi","year":"2017","journal-title":"The Journal of Nutrition, Health & Aging"},{"key":"10.1017\/S1041610223000844_bb0060","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/gps.5494","article-title":"Benzodiazepines and antidepressants: effects on cognitive and functional decline in Alzheimer\u2019s disease and Lewy body dementia","volume":"36","author":"Borda","year":"2021","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0065","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/hup.2456","article-title":"The impact of chronic benzodiazepine use on cognitive evolution in nursing home residents","volume":"30","author":"Bourgeois","year":"2015","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"key":"10.1017\/S1041610223000844_bb0070","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2217\/1745509X.4.3.311","article-title":"Impact of anticholinergics on the aging brain: a review and practical application","volume":"4","author":"Boustani","year":"2008","journal-title":"Aging Health"},{"key":"10.1017\/S1041610223000844_bb0075","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.20com13559","article-title":"Why do some older adults treated with antidepressants progress to dementia?","volume":"81","author":"Brown","year":"2020","journal-title":"The Journal of Clinical Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0080","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2710.2006.00778.x","article-title":"Long-term effects of antidepressants on cognition in patients with Alzheimer\u2019s disease","volume":"31","author":"Caballero","year":"2006","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"key":"10.1017\/S1041610223000844_bb0085","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/j.clinthera.2006.10.008","article-title":"Cognitive effects of atypical antipsychotics in patients with Alzheimer\u2019s disease and comorbid psychiatric or behavioral problems: a retrospective study","volume":"28","author":"Caballero","year":"2006","journal-title":"Clinical Therapeutics"},{"key":"10.1017\/S1041610223000844_bb0090","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/S1878-7649(15)30087-5","article-title":"Antidepressant use and cognitive decline in elderly people","volume":"6","author":"Carriere","year":"2015","journal-title":"European Geriatric Medicine"},{"key":"10.1017\/S1041610223000844_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12916-017-0847-z","article-title":"Antidepressant use and cognitive decline in community-dwelling elderly people - The Three-City Cohort","volume":"15","author":"Carri\u00e8re","year":"2017","journal-title":"BMC Medicine"},{"key":"10.1017\/S1041610223000844_bb0100","doi-asserted-by":"crossref","first-page":"e1003941","DOI":"10.1371\/journal.pmed.1003941","article-title":"Association between lithium use and the incidence of dementia and its subtypes: a retrospective cohort study","volume":"19","author":"Chen","year":"2022","journal-title":"PLoS Medicine"},{"key":"10.1017\/S1041610223000844_bb0105","first-page":"13","article-title":"Psychotropic medications in older adults: a review","volume":"28","author":"Curkovic","year":"2016","journal-title":"Psychiatria Danubina"},{"key":"10.1017\/S1041610223000844_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1017\/S1041610211001359","article-title":"Sedative use and incident cognitive decline among persons aged 75 years and older: a population-based longitudinal study","volume":"24","author":"Desplenter","year":"2012","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610223000844_bb0115","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1212\/WNL.0b013e318230a16c","article-title":"Chronic divalproex sodium use and brain atrophy in Alzheimer disease","volume":"77","author":"Fleisher","year":"2011","journal-title":"Neurology"},{"key":"10.1017\/S1041610223000844_bb0120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/gerona\/glab241","article-title":"Use of benzodiazepines and risk of incident dementia: a retrospective cohort study","volume":"77","author":"Gerlach","year":"2021","journal-title":"The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences"},{"key":"10.1017\/S1041610223000844_bb0125","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1017\/S1041610211002778","article-title":"Depressive symptoms, antidepressant use, and future cognitive health in postmenopausal women: the Women\u2019s Health Initiative Memory Study","volume":"24","author":"Goveas","year":"2012","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610223000844_bb0130","first-page":"i90","article-title":"Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study","volume":"352","author":"Gray","year":"2016","journal-title":"BMJ (Clinical Research ed.)"},{"key":"10.1017\/S1041610223000844_bb0135","doi-asserted-by":"crossref","first-page":"e0227924","DOI":"10.1371\/journal.pone.0227924","article-title":"Estimating associations between antidepressant use and incident mild cognitive impairment in older adults with depression","volume":"15","author":"Han","year":"2020","journal-title":"PloS One"},{"key":"10.1017\/S1041610223000844_bb0140","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1111\/jgs.15508","article-title":"Cumulative antidepressant use and risk of dementia in a prospective cohort study","volume":"66","author":"Heath","year":"2018","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610223000844_bb0145","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jad.2017.09.016","article-title":"Potentially inappropriate medication: association between the use of antidepressant drugs and the subsequent risk for dementia","volume":"226","author":"Heser","year":"2018","journal-title":"Journal of Affective Disorders"},{"key":"10.1017\/S1041610223000844_bb0150","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-981-13-3681-2_5","article-title":"Ageing and cognition","volume":"91","author":"Juan","year":"2019","journal-title":"Subcellular Biochemistry"},{"key":"10.1017\/S1041610223000844_bb0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3233\/JAD-200994","article-title":"Atypical antipsychotics augmentation in patients with depressive disorder and risk of subsequent dementia: a nationwide population-based cohort study","volume":"80","author":"Kim","year":"2021","journal-title":"Journal of Alzheimers Disease"},{"key":"10.1017\/S1041610223000844_bb0160","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.jagp.2019.05.019","article-title":"Exposure to antidepressant medication and the risk of incident dementia","volume":"27","author":"Kodesh","year":"2019","journal-title":"The American Journal of Geriatric Psychiatry: Official Journal of the American Association for Geriatric Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0165","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.neubiorev.2017.03.007","article-title":"Serotonin and neuroplasticity - links between molecular, functional and structural pathophysiology in depression","volume":"77","author":"Kraus","year":"2017","journal-title":"Neuroscience & Biobehavioral Reviews"},{"key":"10.1017\/S1041610223000844_bb0170","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3233\/JAD-181145","article-title":"Long-term trazodone use and cognition: a potential therapeutic role for slow-wave sleep enhancers","volume":"67","author":"La","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1017\/S1041610223000844_bb0175","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0140-6736(20)30367-6","article-title":"Dementia prevention, intervention, and care: 2020 report of the Lancet Commission","volume":"396","author":"Livingston","year":"2020","journal-title":"The Lancet"},{"key":"10.1017\/S1041610223000844_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/B978-0-12-804766-8.00009-1","article-title":"Epidemiology of aging and associated cognitive disorders: prevalence and incidence of Alzheimer\u2019s disease and other dementias","volume":"167","author":"Lopez","year":"2019","journal-title":"Handbook of Clinical Neurology"},{"key":"10.1017\/S1041610223000844_bb0185","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S104161022000174X","article-title":"Use of tricyclic antidepressants and other anticholinergic medicines by older Aboriginal Australians: association with negative health outcomes","volume":"34","author":"Mate","year":"2022","journal-title":"International Psychogeriatrics"},{"key":"10.1017\/S1041610223000844_bb0190","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s40264-020-00992-7","article-title":"Patterns of benzodiazepine use and excess risk of all-cause mortality in the elderly: a nationwide cohort study","volume":"44","author":"Mathieu","year":"2021","journal-title":"Drug Safety"},{"key":"10.1017\/S1041610223000844_bb0195","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a treatment for Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"48","author":"Matsunaga","year":"2015","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1017\/S1041610223000844_bb0200","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/bmj.314.7076.266","article-title":"Do neuroleptic drugs hasten cognitive decline in dementia? Prospective study with necropsy follow up","volume":"314","author":"McShane","year":"1997","journal-title":"BMJ"},{"key":"10.1017\/S1041610223000844_bb0205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.euroneuro.2012.05.004","article-title":"Chronic use of benzodiazepines and latent cognitive decline in the elderly: results from the three-city study","volume":"23","author":"Mura","year":"2013","journal-title":"European Neuropsychopharmacology"},{"key":"10.1017\/S1041610223000844_bb0210","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1060028019882037","article-title":"Is benzodiazepine use associated with the risk of dementia and cognitive impairment-not dementia in older persons? The Canadian study of health and aging","volume":"54","author":"Nafti","year":"2020","journal-title":"Annals of Pharmacotherapy"},{"key":"10.1017\/S1041610223000844_bb0215","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0301-0082(02)00011-4","article-title":"Dopamine and the regulation of cognition and attention","volume":"67","author":"Nieoullon","year":"2002","journal-title":"Progress in Neurobiology"},{"key":"10.1017\/S1041610223000844_bb0220","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/00019052-200312002-00002","article-title":"Dopamine: a key regulator to adapt action, emotion, motivation and cognition","volume":"16","author":"Nieoullon","year":"2003","journal-title":"Current Opinion in Neurology"},{"key":"10.1017\/S1041610223000844_bb0225","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/jgs.16970","article-title":"Psychotropic medication and cognitive, functional, and neuropsychiatric outcomes in Alzheimer\u2019s disease (AD)","volume":"69","author":"Oh","year":"2021","journal-title":"Journal of the American Geriatrics Society"},{"key":"10.1017\/S1041610223000844_bb0230","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1176\/appi.ajp.2019.19030315","article-title":"Associations of benzodiazepines, Z-drugs, and other anxiolytics with subsequent dementia in patients with affective disorders: a nationwide cohort and nested case-control study","volume":"177","author":"Osler","year":"2020","journal-title":"The American Journal of Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0235","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","article-title":"Benzodiazepines and injurious falls in community dwelling elders","volume":"25","author":"Pariente","year":"2008","journal-title":"Drugs & Aging"},{"key":"10.1017\/S1041610223000844_bb0240","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-181102","article-title":"Effects of psychotropic medication on cognition, caregiver burden, and neuropsychiatric symptoms in Alzheimer\u2019s disease over 12 months: results from a prospective registry of dementia in Austria (PRODEM)","volume":"71","author":"Pirker-Kees","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease: JAD"},{"key":"10.1017\/S1041610223000844_bb0245","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1017\/S146114570600705X","article-title":"The effects of acute tryptophan depletion and serotonin transporter polymorphism on emotional processing in memory and attention","volume":"10","author":"Roiser","year":"2007","journal-title":"The International Journal of Neuropsychopharmacology"},{"key":"10.1017\/S1041610223000844_bb0250","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.jalz.2015.10.006","article-title":"Benzodiazepine, psychotropic medication, and dementia: a population-based cohort study","volume":"12","author":"Shash","year":"2016","journal-title":"Alzheimer\u2019s & Dementia: the Journal of the Alzheimer\u2019s Association"},{"key":"10.1017\/S1041610223000844_bb0255","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-190577","article-title":"Neurotransmitter imbalance in the brain and Alzheimer\u2019s disease pathology","volume":"72","author":"Snowden","year":"2019","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"10.1017\/S1041610223000844_bb0260","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/acps.13380","article-title":"The risk of dementia in patients using psychotropic drugs: antidepressants, mood stabilizers or antipsychotics","volume":"145","author":"Tournier","year":"2022","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1017\/S1041610223000844_bb0265","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/gps.2143","article-title":"Use of benzodiazepines, depressive symptoms and cognitive function in old age","volume":"24","author":"van Vliet","year":"2009","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0270","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1176\/appi.ajp.2011.08121844","article-title":"Cognitive effects of atypical antipsychotic medications in patients with Alzheimer\u2019s disease: outcomes from CATIE-AD","volume":"168","author":"Vigen","year":"2011","journal-title":"American Journal of Psychiatry"},{"key":"10.1017\/S1041610223000844_bb0275","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1097\/WAD.0000000000000103","article-title":"Antidepressant use in the elderly is associated with an increased risk of dementia","volume":"30","author":"Wang","year":"2016","journal-title":"Alzheimer Disease and Associated Disorders"}],"container-title":["International Psychogeriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610225002698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1041610225002698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1041610223000844","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T07:41:42Z","timestamp":1778917302000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1041610225002698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":54,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1041610225002698"],"URL":"https:\/\/doi.org\/10.1017\/s1041610223000844","relation":{},"ISSN":["1041-6102"],"issn-type":[{"value":"1041-6102","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of psychotropic medications on cognition among older adults: a systematic review","name":"articletitle","label":"Article Title"},{"value":"International Psychogeriatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1017\/S1041610223000844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 The Author(s), 2023. Published by Cambridge University Press on behalf of International Psychogeriatric Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}